The European Medicines Agency (EMA) has determined that the hair loss medication finasteride carries a rare risk of suicidal thoughts. After reviewing 313 reports, the EMA concluded that while the frequency of this side effect is unknown, the benefits of the drug outweigh its risks. New warnings will be added to the medication, advising users to seek medical advice if they experience mood changes. Teljes cikk (Euronews.com)